Related Experiment Video
Updated: Feb 2, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Two Mutations Commonly Associated with Daptomycin Resistance in Enterococcus faecium LiaST120A and LiaRW73C Appear To
Milya Davlieva1, Chelsea Wu1, Yue Zhou1
1Department of Biosciences , Rice University , Houston , Texas 77005 , United States.
Abstract:
The cyclic antimicrobial lipopeptide daptomycin is now frequently used as a first-line therapy in serious infections caused by multidrug-resistant Enterococcus faecium. Resistance to daptomycin in E. faecium is mediated by activation of the LiaFSR membrane stress response pathway. Deletion of liaR, encoding the response regulator of the system, restores susceptibility to daptomycin, suggesting that the LiaFSR pathway is a potential target for the development of drugs that would induce hypersusceptibility to daptomycin and make it more difficult for enterococci to become daptomycin-resistant. In clinical isolates of E. faecium, substitutions in the membrane-bound histidine kinase LiaS (T120A) and its response regulator LiaR (W73C) are found together, suggesting a potential epistatic relationship in daptomycin resistance. Using in vitro phosphorylation studies, we show that while the phosphotransfer rate of wild-type LiaS and LiaST120A to either wild-type LiaR or LiaRW73C remains rapid and comparable, the LiaS-dependent dephosphorylation rate of phosphorylated LiaRW73C is markedly higher. When the two adaptive mutants LiaRW73C and LiaST210A are paired, however, LiaS-mediated LiaR dephosphorylation is restored back to wild-type levels. Taken together with earlier work showing that LiaRW73C leads to an increased level of oligomerization and subsequently favors an increased level of transcription of the LiaFSR regulon, the net effect of the two commonly found LiaST120A and LiaRW73C alleles would be to coordinately increase the strength and persistence of LiaFSR signaling and decrease daptomycin susceptibility. The in vitro approaches developed in this work also provide the basis for screens for identifying drug candidates that inhibit the LiaFSR pathway.
Insights
Daptomycin resistance in Enterococcus faecium involves the LiaFSR pathway. Specific mutations in LiaS and LiaR enhance this pathway, increasing resistance. Understanding these interactions could lead to new therapies against resistant infections.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Resistance
Background:
- Daptomycin is crucial for treating multidrug-resistant Enterococcus faecium infections.
- Resistance often arises from the LiaFSR membrane stress response pathway.
- Identifying resistance mechanisms is key to developing effective treatments.
Purpose of the Study:
- Investigate the epistatic relationship between LiaS and LiaR mutations in daptomycin resistance.
- Characterize the in vitro biochemical behavior of these resistance-associated mutations.
- Explore the LiaFSR pathway as a potential drug target.
Main Methods:
- In vitro phosphorylation assays to study protein interactions.
- Analysis of phosphotransfer and dephosphorylation rates.
- Examination of LiaS-LiaR interactions in the presence of specific mutations.
Main Results:
- LiaST120A mutation increases LiaRW73C dephosphorylation.
- Combined LiaST120A and LiaRW73C mutations enhance LiaFSR signaling.
- This coordinated effect decreases daptomycin susceptibility in E. faecium.
Conclusions:
- The LiaST120A and LiaRW73C mutations work together to strengthen LiaFSR signaling, promoting daptomycin resistance.
- The developed in vitro methods can screen for inhibitors of the LiaFSR pathway.
- Targeting the LiaFSR pathway offers a strategy to combat daptomycin resistance.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Common Ion Effect
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms

